HERE AT THE MOSS REPORTS
We are dedicated to bringing our readers and clients the latest
and most interesting developments in the field of cancer research
and treatment.
The Moss Reports is a comprehensive
series of detailed individual reports on more than 200 different
kinds of cancer. Each of these diagnosis-specific reports
analyzes the current available treatments, both conventional
and alternative, and offers the cancer patient a clear-eyed,
truthful assessment of the available options. If you would
like to purchase a Moss Report for
yourself or someone you love, you can do so securely from
our Web site (www.cancerdecisions.com),
or by calling 1-800-980-1234 (814-238-3367
from outside the US).
I also offer phone consultations to clients
who have bought a Moss Report.
A phone consultation can be enormously helpful in drawing
up a treatment strategy and getting one's options clearly
prioritized. We recently received the following comment from
a husband and wife who had a joint consultation:
"We felt that speaking to Dr. Moss was a great gift.
He has a wealth of information, which we were able to receive
because the person we were speaking to was unbiased and
had such an obvious concern for humankind." –
Clients O. and S. L., April 2006
To schedule an appointment for a phone consultation, please
email Jacquie@cancerdecisions.com,
or call 1-800-980-1234 (814-238-3367 from
outside the US).
We look forward to helping you.
CULTIVATING THE ANTICANCER GARDEN
There are over 70 million gardeners in the United States,
and countless more worldwide. For many of us, this is the
time of year to finally stop vacillating and decide which
seeds and plants are going to go into the ground. I spend
my summers in a cool climate and the growing season is rather
short. I try to make planting choices with one eye on my plants'
anticancer potential. So let's see how a few common garden
varieties stack up, especially in the light of recent scientific
studies.
Last year, I thinned 50 feet of red raspberries and transplanted
the remaining canes into 30 additional feet in a sunny area
behind the house. Soon I'll find out how well this no-cost
maneuver has worked. If these canes are not productive, I
will buy some new plants from the local nursery and may even
put in a row of black raspberries, just for a change of pace.
I need to have a superabundance of berries because the resident
gremlins - my grandchildren, who do most of the picking -
extract a tax in fresh berries whenever they go to work. In
addition, a young lady of the household appropriates the lioness's
share for jams and jellies. (I know, I know – sugar
is bad for you, but a little raspberry jam evokes a Proustian
remembrance of summer past on a chilly winter morning.)
What else can berries do for you? They are among the most
potent and readily available sources of antioxidants on the
planet. A few years back, wild blueberries were found to have
a super high score on the antioxidant (ORAC) scale. Mainers
crowed – you would have thought the Black Bears had
won the A-10 football conference.
But no one has a monopoly in the berry sweepstakes. Scientists
at Ohio State University have now weighed in with favorable
reports of their own on black raspberries, the kind that I
generally gather in the sunny edges of woodland clearings.
In 2006, these Buckeye State scientists studied the cancer
preventing effects of black raspberry extracts on a model
of esophageal cancer in mice. Esophageal cancer is difficult
to treat, and so any positive news on this front is most welcome.
Tumor-bearing animals were fed a diet containing 5 percent
black raspberries (more than humans are likely to consume,
but good at bringing out effects in a study). After 25 weeks
on this regimen, mice that ate black raspberries had approximately
half as many tumors as control animals (3.78 vs. 2.23).
No one is quite sure exactly how this tumor-suppressing effect
works. Black raspberries are a natural COX-2 inhibitor, and
we saw in previous newsletters how Celebrex, a synthetic COX-2
inhibitor, reduced the formation of colon polyps. So perhaps
the same mechanism is at work – although I would be
dumbfounded if black raspberries also caused cardiovascular
disease, the way Celebrex did in the latest studies. Raspberries
also reduced certain other markers of cancer formation. The
scientists said it had a "novel tumor suppressive role...."
(Chen 2006). So how's that for a pleasurable way of helping
to prevent a deadly disease?
Another plant that I have in my garden is horseradish (Armoracia
rusticana). Its leaves grow absolutely huge. Usually
once per summer, my garden helpers, mistaking them for the
pesky comfrey that is always ready, willing and able to invade
the planting beds, mow the horseradishes down to the ground.
The redoubtable plant doesn't seem to mind - the leaves pop
right up by the next mowing. Anyway, it is the roots that
you want for making horseradish sauce, not the leaves.
Last year, scientists at Michigan State University found
that both common horseradish and the extra-pungent Japanese
wasabi (Wasabia japonica) contained certain ingredients
called monogalactosyl diacylglycerides. These too were found
to restrict the growth of cancer cells. Three active ingredients
in horseradish and two from wasabi were tested. Compound no.
3 from horseradish inhibited the proliferation of colon cancer
cells by as much as 68.4 percent and inhibited lung cancer
cells by as much as 71 percent. Compound no. 4 from wasabi
inhibited the growth of colon, lung and stomach cancer cells
by as much as 44 percent (Weil 2005). These are encouraging
results.
You can buy reasonably fresh horseradish from the supermarket's
dairy case. (Look for the kind that has nothing but ground
root and a little vinegar.) Alternatively you can make a much
better horseradish sauce yourself if you have a spade to excavate
your two-year roots. You will also need a sturdy vegetable
peeler and a blender or food processor. You can then mix the
macerated homegrown horseradish with vinegar or with sour
cream.
A Surprising Herb
In the herb department, I wouldn't be without feverfew. Many
readers know the feverfew plant (Tanacetum parthenium),
a member of the Chrysanthemum family, sometimes called bachelor's
buttons. This is a cheerful-looking perennial, with a profusion
of white pompon-like blooms - like a shower of tiny daisies.
As the name implies, this is a traditional remedy for fevers.
It also has a long association with the relief of migraines.
(I keep some feverfew pills in the medicine chest in case
any of my summer visitors are plagued with that mysterious
form of torture.) But feverfew is particularly interesting
for its anticancer potential.
You may remember from my earlier newsletters that scientists
are now reevaluating all cancer drugs for their effect on
malignant stem cells. These are the primitive cells that appear
to be fundamentally responsible for the malignant dimensions
of cancer. Many conventional cancer drugs are turning out
to have a limited ability to kill these cells. That is why
feverfew is so interesting.
Scientists at the University of Rochester Medical Center
have found that an extract of feverfew is effective against
a type of human leukemia. Monica L. Guzman, PhD, and Craig
T. Jordan, PhD, reported that feverfew extracts kill malignant
stem cells like no other single therapy they have tested.
The active ingredient is derived from parthenolide, one of
a class of sesquiterpene lactones found in the plant. The
US National Cancer Institute (NCI) has been sufficiently excited
by this work to accept it into the rapid access program, which
aims to move experimental drugs from the laboratory to human
clinical trials as quickly as possible.
"This research is a very important step in setting the
stage for future development of a new therapy for leukemia,"
said Dr. Jordan. "We have proof that we can kill leukemia
stem cells with this type of agent, and that is good news."
What is particularly exciting is that this feverfew extract
is the first agent known to destroy myeloid leukemia at the
level of the stem cells. Increasingly, cancer research is
homing in on these primordial cells as the source of cancer.
An increasing number of scientists believe that unless cancer
is attacked at this level it can rarely be controlled, much
less cured.
A 2006 study from Clemson University in North Carolina showed
that parthenolide, considered the primary bioactive compound
in golden feverfew, has anti-tumor activity. The scientists
studied it against two human breast cancer and one human cervical
cancer cell line. "Feverfew...extract inhibited the growth
of all three types of cancer cells," they wrote. Of four
feverfew components, parthenolide showed the highest inhibitory
effect, although the other compounds work in concert with
it in inhibiting cancer.
A 2004 phase I clinical trial from Purdue University in Indiana
gave patients oral doses of feverfew, with up to 4 milligrams
(mg) of parthenolide. The daily oral tablet was "well
tolerated without dose-limiting toxicity." However, curiously,
it did not provide detectable concentrations in the blood.
So its exact mode of action remains a mystery (Currey 2004).
You can buy feverfew capsules in the health food store or
over the Internet. For instance, one popular preparation of
feverfew leaf sells for around 5¢ per 380 mg capsule.
The manufacturer recommends one capsule three times per day,
which brings the cost to around 15¢ to 20¢ per day.
(This is considerably less expensive than many poorly documented
anticancer drugs, such as Avastin, now selling for $100,000
per year.) The extract, Tanacet, used in the above-mentioned
phase I clinical trial, is sometimes available over the Internet,
as well.
You can also grow feverfew yourself. Johnny's Selected Seeds
of Winslow, Maine, one of my favorite providers, offers 500
organically grown feverfew seeds for just $3.20. This cheerful
plant is a perennial in temperate climates and will self-seed
in colder climates. So a $3.20 investment can provide you
with all the feverfew you are ever likely to need. No one
can guarantee this herb will have any clinical anticancer
effects. But, at the very least, these little charmers will
adorn your kitchen table with a bouquet that is, to me, the
very essence of summer.
--Ralph W. Moss, Ph.D.
References:
Chen T, Hwang H, Rose ME, Nines
RG, Stoner GD. Chemopreventive properties of black
raspberries in N-nitrosomethylbenzylamine-induced rat esophageal
tumorigenesis: down-regulation of cyclooxygenase-2, inducible
nitric oxide synthase, and c-Jun. Cancer Res. 2006;66:2853-2859.
Curry EA 3rd, Murry DJ, Yoder C,
et al. Phase I dose escalation trial of feverfew
with standardized doses of parthenolide in patients with cancer.
Invest New Drugs. 2004;22:299-305.
Weil MJ, Zhang Y, Nair MG.
Tumor cell proliferation and cyclooxygenase inhibitory constituents
in horseradish (Armoracia rusticana) and Wasabi (Wasabia japonica).
J Agric Food Chem. 2005;53:1440-1444.
**NOTE** To view
this page in a more printable format, please CLICK
HERE.
IMPORTANT DISCLAIMER
The news and other items in this newsletter
are intended for informational purposes only. Nothing in this
newsletter is intended to be a substitute for professional
medical advice.
 |
|
CancerDecisions®
PO Box 1076, Lemont, PA 16851
Phone Toll Free: 800-980-1234 | Fax: 814-238-5865
Copyright
© 1996-2006 All Rights Reserved
|
|
|